Novartis AG

CH

NOVN

Health Care

95.12 ₽

Current price

Hold
95.12 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    678 / 1328

  • Position in country

    267 / 449

  • Return on Assets, %

    7.7

    -2.7

  • Net income margin, %

    22.4

    2.8

  • EBITDA margin, %

    39.8

    10.8

  • Debt to Equity, %

    56.4

    19.2

  • Intangible assets and goodwill, %

    50.2

    3.6

  • Revenue CAGR 3Y, %

    -2.3

    8.5

  • Total Equity change 1Y, %

    -21.4

    0

  • Revenue Y, % chg

    7.2

    0.5

  • P/E

    22.7

    22.7

  • P/BV

    4

    1.5

  • P/S

    4.3

    2.3

  • EV/S

    4.7

    2.4

  • EV/EBITDA

    10.2

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    19.8

    51.3

  • Forward P/E

    12.7

    15.6

  • Dividend Yield, %

    3.9

    1.7

  • Forward Dividend Yield, %

    3.9

    0.2

  • Expected dividend per share

    3.7

    0

  • Payout Ratio, %

    82.2

    30.3

  • Dividend Ex Date

    2024-03-07

Get an analytical review of this company

Competitors

Ranks

  • Novo Nordisk A/S

    00%

  • Vifor Pharma AG

    00%

  • AstraZeneca PLC

    00%

  • Eli Lilly and Co

    00%

  • Roche Holding AG

    00%

  • Dottikon Es Holding AG

    00%

  • Novartis AG

    00%

  • Sandoz Group AG

    00%

  • Johnson & Johnson

    00%

  • Merck & Co Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Switzerland

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    207246.6

  • Ticker

    NVS.N

  • ISIN

    US66987V1098

  • IPO date

    2001-05-07

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-01-31

  • Date fact. publication of reports

    2023-12-31

Company Description

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.